section name header

Basics

Herbert B. Newton, MD, FAAN


BASICS

DESCRIPTION

Rheumatoid arthritis (RA) is a chronic multisystem immune complex disease. Extra-articular manifestations occur in 10–20% of patients. Neurologic complications usually occur in patients with moderate to severe RA and can involve the central and peripheral nervous systems (CNS, PNS), including the spine. Chronic synovitis of the spine typically occurs in the cervical region, with damage to the atlantoaxial complex. Complications affecting the PNS are frequent, with carpal tunnel syndrome (CTS; compression neuropathy of the median nerve) being most common.

EPIDEMIOLOGY

Incidence/Prevalence

RISK FACTORS

Atlantoaxial subluxation (AAS) is more likely in patients with RA of 10 years or more duration, seropositivity, erosive and deforming peripheral joint disease, and male gender. Compression neuropathies correlate with the severity of local synovitis. Vasculitis is more likely to occur in patients with long-standing RA; the incidence is higher in males.

Pregnancy Considerations

A hormonal role is suspected in disease expression, because there is an increased risk of RA in nulliparous women and a possible protective effect in women that use oral contraceptives.

Genetics

There can be a genetic predisposition for RA; first-degree relatives of seropositive patients are four times more likely to develop RA than controls.

GENERAL PREVENTION

There are no preventive measures available.

PATHOPHYSIOLOGY/ETIOLOGY

RA is mediated by interaction of autoantibodies, such as rheumatoid factor (IgM or IgG class), with circulating immunoglobulins. The immune complexes are composed of IgG combined with IgM or IgG anti-IgG antibodies. Deposition of the immune complexes into the joints and soft tissues induces activation of complement and other inflammatory pathways. AAS results from rheumatoid synovial tissue-induced laxity or destruction of the transverse ligament in combination with odontoid erosion. Subaxial subluxation can occur with rheumatoid involvement of the longitudinal ligaments, vertebral endplates, apophyseal joints, and intervertebral discs. Peripheral neuropathy results from entrapment, segmental demyelination, or rheumatoid vasculitis of the small-to-medium size vessels. Nerve entrapment syndromes arise from inflamed synovial sacs and can affect the median, ulnar, and posterior tibial nerves.

COMMONLY ASSOCIATED CONDITIONS

There is a higher incidence of vasculitic complications in RA patients with Felty's syndrome (i.e., RA, splenomegaly, neutropenia, anemia, and thrombocytopenia).

Diagnosis

DIAGNOSIS

HISTORY

PHYSICAL EXAM

Variable depending on the specific region on involvement, as noted above.

DIAGNOSTIC TESTS AND INTERPRETATION

Lab

Initial Lab Tests

Serological testing for rheumatoid factor and other autoantibodies is necessary.

Imaging

Initial Approach

Diagnostic Procedures/Other

Somatosensory evoked potentials can evaluate the functional integrity of central sensory pathways. Disease processes affecting the cervical spinal cord may produce prolongation of wave and interwave latencies recorded along these pathways. Electromyography and sensory nerve conduction studies are the most accurate method to diagnose compression neuropathies and peripheral neuropathies. Sural nerve biopsies can be helpful if the diagnosis of vasculitis is unclear.

Pathological Findings

Pathological findings include synovial inflammation, formation of invasive rheumatoid synovial tissue or pannus, and vasculitis.

DIFFERENTIAL DIAGNOSIS

The differential diagnosis is broad and includes other causes of myelopathy, cervical subluxation disorders, CNS and PNS vasculitis, entrapment neuropathies, and peripheral neuropathy. RA must be distinguished from degenerative osteoarthritis and from deforming inflammatory arthritis associated with other connective tissue disorders.

Treatment

TREATMENT

MEDICATION

First Line

Pharmacotherapy of neurological manifestations of RA consists of a combination of corticosteroids and a cytotoxic agent, such as oral cyclophosphamide or methotrexate. The corticosteroid is started at 60–100 mg/day and then tapered over several weeks. Monotherapy with one of the cytotoxic agents is then continued for long-term maintenance therapy. The efficacy of other immunosuppressive therapies such as plasmapheresis and IVIG is unknown.

ADDITIONAL TREATMENT

General Measures

Additional Therapies

Soft cervical collars can stabilize the spine and reduce neck pain in patients with severe AAS. Local corticosteroid injections and splints may be of benefit for compression neuropathies.

COMPLEMENTARY AND ALTERNATIVE THERAPIES

Simple neck traction may be helpful in patients with severe AAS or subaxial subluxation. Physical and occupational therapy should be considered for patients with myelopathy, peripheral neuropathy, and other forms of weakness.

SURGERY/OTHER PROCEDURES

IN-PATIENT CONSIDERATIONS

Admission Criteria

Admission is uncommon except in cases of acute neurological deterioration where the diagnosis is indeterminate or therapeutic intervention is necessary. Patients with CNS or PNS vasculitis are the most likely subgroup to require admission, usually for weakness, seizures, encephalopathy, gait dysfunction, or other acute complications.

Discharge Criteria

Variable depending on specific complication.

Ongoing Care

ONGOING-CARE

FOLLOW-UP RECOMMENDATIONS

Variables will be depending on the specific syndrome involved.

Patient Monitoring

Rheumatoid arthritis patients that should be screened for AAS with radiographic evaluation include those with posterior skull and/or neck pain and stiffness, and patients with long-standing erosive RA in whom radiographs have not been done within the previous 2 or 3 years. Serial neurological examinations and appropriate follow-up testing (e.g., MRI of the brain or spine, electromyography and nerve conduction testing) will be necessary.

PATIENT EDUCATION

PROGNOSIS

The best course of management is to prevent significant morbidity in RA. Aggressive immunosuppressant therapy will reduce the neurological complications of RA. The overall 5-year mortality rate of RA patients with radiographic evidence of cervical subluxations (with or without neurologic symptoms) is similar to severe RA patients without cervical involvement. The risk of developing upper cervical spinal cord compression secondary to anterior AAS is increased by male sex, anterior subluxation >9 mm, and coexistent atlantoaxial impaction. There is a higher incidence of fatality with basilar invagination. The prognosis of rheumatoid vasculitis is poor. Independent variables that best predict mortality include cutaneous vasculitis, multifocal neuropathy, and depressed C4 level.

COMPLICATIONS

Variables as noted above.

Additional Reading

SEE-ALSO

Codes

CODES

ICD9

Clinical Pearls